Search results for "Secondary"

showing 10 items of 1765 documents

No evidence of androgenic hormone from the testes of the glowworm, Lampyris noctiluca.

2005

The widely accepted concept, stating that insects have no true sex hormones, and that primary as well as secondary sex characteristics are controlled by the genetic inventory of each single cell, is challenged by the report of Naisse, J. [1966a. Controle endocrinien de la differenciation sexuelle chez l'Insecte Lampyris noctiluca (Coleoptere Malacoderme Lampyride). I. Role androgene des testicules, Arch. Biol. Liege, 77, 139-201] on the discovery of an androgenic hormone in the glowworm, Lampyris noctiluca. This case is of special interest, since it may point to an ancestral mode of sex differentiation in arthropods, considering that androgenic hormones have been discovered and characterize…

Malemedicine.medical_specialtySex Differentiationmedicine.drug_classSecondary sex characteristicPhysiologyOvaryEndocrinologyInternal medicineTestismedicineAnimalsGlowwormSexual differentiationbiologyOvaryAndrogenbiology.organism_classificationTransplantationColeopteramedicine.anatomical_structureEndocrinologyLarvaAndrogensLampyris noctilucaAnimal Science and ZoologyFemaleVitellogenesisGeneral and comparative endocrinology
researchProduct

Genetic and environmental influences on pubertal timing assessed by height growth

2008

Secular trends towards earlier puberty, possibly caused by new environmental triggers, provide a basis for periodic evaluation of the influence and interaction of genetic and environmental effects on pubertal timing. In such studies, a practical marker that reflects timing of puberty in both genders needs to be used. We investigated genetic and environmental influences on pubertal timing by using change in the relative height between early and late adolescence (HD:SDS, height difference in standard deviations) as a new marker of pubertal timing. HD:SDS correlated well with age at peak height velocity in a population of men and women with longitudinal growth data. In 2,309 twin girls and 1,8…

Malemedicine.medical_specialtyTime FactorsAdolescentpuberteettiSecondary sex characteristicPopulation030209 endocrinology & metabolismBiologyArticle03 medical and health sciences0302 clinical medicineReference ValuesSurveys and Questionnaires030225 pediatricsInternal medicineGenetic modelGeneticsmedicineHumansChild10. No inequalityeducationEcology Evolution Behavior and Systematicseducation.field_of_studyModels StatisticalModels GeneticPubertyLongitudinal growthAge FactorsEnvironmental ExposureEnvironmental exposureHeight differenceLate adolescenceBody HeightSecular variationEndocrinologyAnthropologyFemaleAnatomyDemographyAmerican Journal of Human Biology
researchProduct

Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Pat…

2020

Background Risk stratification among patients with coronary artery disease ( CAD ) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase‐type plasminogen activator receptor (su PAR ) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD . Methods and Results Plasma levels of su PAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography—including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main o…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial InfarctionRenal functionCoronary Artery Disease030204 cardiovascular system & hematologyKidneyRisk AssessmentReceptors Urokinase Plasminogen Activatorsoluble urokinase‐type plasminogen activator receptorTroponin CCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineSecondary PreventionmedicineHumanscardiovascular diseasesMyocardial infarctionReceptorAgedOriginal Research030304 developmental biologyUrokinase0303 health sciencesbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinC-Reactive ProteinHeart Disease Risk FactorsCardiologybiomarkerBiomarker (medicine)FemaleKidney DiseasesCardiology and Cardiovascular MedicinebusinessPlasminogen activatorBiomarkersGlomerular Filtration Ratemedicine.drugJournal of the American Heart Association
researchProduct

Long‐Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta‐…

2018

Background Uncertainties remain about the current risk of myocardial infarction ( MI ) after ischemic stroke or transient ischemic attack. Methods and Results We undertook a systematic review to estimate the long‐term risk of MI , compared to recurrent stroke, with temporal trends in ischemic stroke/transient ischemic attack patients. Annual risks and 95% confidence intervals (95% CI ) of MI and recurrent stroke were estimated using random‐effect meta‐analyses. We calculated incidence ratios of MI /recurrent stroke, for fatal and nonfatal events, using similar analyses. Rate ratios for MI in patients with potential risk factors compared to those without were calculated using Poisson regres…

Malemedicine.medical_specialtyTime FactorsMyocardial Infarctionischemic030204 cardiovascular system & hematologyRisk AssessmentBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineRecurrenceRisk FactorsRecurrent strokeCause of DeathInternal medicineSecondary PreventionmedicineHumansMyocardial infarctionStrokeAgedIschemic StrokeCause of deathSystematic Review and Meta‐Analysisbusiness.industryIncidenceTransient Ischemic Attack (TIA)Middle AgedPrognosismedicine.diseasestrokeIschemic Attack TransientMeta-analysisIschemic strokeCardiologyFemaleCardiology and Cardiovascular MedicineRisk assessmentbusiness030217 neurology & neurosurgeryJournal of the American Heart Association
researchProduct

Exercise Adherence and Effect of Self-Regulatory Behavior Change Techniques in Patients Undergoing Curative Cancer Treatment: Secondary Analysis from…

2020

Introduction: Adherence to exercise interventions in patients with cancer is often poorly described. Further, it is unclear if self-regulatory behavior change techniques (BCTs) can improve exercise adherence in cancer populations. We aimed to (1) describe exercise adherence in terms of frequency, intensity, time, type (FITT-principles) and dropouts, and (2) determine the effect of specific self-regulatory BCTs on exercise adherence in patients participating in an exercise intervention during curative cancer treatment. Methods: This study was a secondary analysis using data from a Swedish multicentre RCT. In a 2×2 factorial design, 577 participants recently diagnosed with curable breast, col…

Malemedicine.medical_specialtyadjuvant treatmentexercise prescriptionphysical activitylcsh:RC254-282law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawBehavior TherapySecondary analysismedicineHumansIn patientadherenceSjukgymnastikExercisePhysiotherapySport and Fitness Sciencesbusiness.industryIdrottsvetenskapbehavioral interventionCancerProstatic NeoplasmsBehavior change methodsResistance Training030229 sport scienceslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseCancer treatmentPeer reviewExercise TherapyComplementary and alternative medicineVDP::Medisinske Fag: 700::Helsefag: 800030220 oncology & carcinogenesisExercise and Cancer TreatmentoncologyPhysical therapyExercise prescriptionbusinessResearch Articlebehavior change support
researchProduct

Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review

2020

Reduction of hazard risk of cerebral ischemic event (stroke, transient ischemic attack (TIA)) represents the hard point to be achieved from primary or secondary preventive strategy in the best clinical practice. However, results from clinical trials, recommendations, guidelines, systematic review, expert opinions, and meta-analysis debated on the optimal pharmacotherapy to achieve the objective. Aspirin and a number of antiplatelet agents, alone or in combination, have been considered from large trials focused on stroke prevention. The present review summarizes, discusses results from trials, and focuses on the benefits or disadvantages originating from antiplatelet drugs. Sections of the r…

Malemedicine.medical_specialtyaspirinHealth Toxicology and Mutagenesisdipyridamolelcsh:MedicineStroke.Review030204 cardiovascular system & hematology03 medical and health sciencesTherapeutic approach0302 clinical medicinePharmacotherapyDouble-Blind MethodpreventionSecondary PreventionmedicineHumanscardiovascular diseasesIntensive care medicineStrokeAgedclopidogrelAspirinPreventive strategybusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMiddle AgedClopidogrelmedicine.diseasestrokecombined drug therapyClinical trialDiabetes Mellitus Type 2Ischemic Attack TransientStroke preventionDrug Therapy CombinationFemalebusinesscilostazolPlatelet Aggregation Inhibitors030217 neurology & neurosurgerymedicine.drugInternational Journal of Environmental Research and Public Health
researchProduct

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

2018

International audience; These practice guidelines on the management of arterial hypertension are a concise summary of the more extensive ones prepared by the Task Force jointly appointed by the European Society of Hypertension and the European Society of Cardiology. These guidelines have been prepared on the basis of the best available evidence on all issues deserving recommendations; their role must be educational and not prescriptive or coercive for the management of individual subjects who may differ widely in their personal, medical and cultural characteristics. The members of the Task Force have participated independently in the preparation of these guidelines, drawing on their academi…

Malemedicine.medical_specialtyblood pressure measurementAdvisory Committees030204 cardiovascular system & hematologycombination therapyPotential conflict03 medical and health sciences0302 clinical medicineDevice therapyInternal medicineLifestyle interventionsecondary hypertensionInternal MedicineHumansMedicinedevice therapyadherence030212 general & internal medicineSocieties MedicalComputingMilieux_MISCELLANEOUSlifestyle interventionshypertension-mediated organ damageTask forcebusiness.industryGeneral Medicinespecial conditionsdrug therapy3. Good healthEuropeHypertensionBlood pressureCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCardiology and Cardiovascular Medicinebusinessblood pressure treatment thresholds and targets
researchProduct

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study

2015

Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during…

Malemedicine.medical_specialtylcsh:MedicineRenal functionCoronary Artery DiseaseCoronary artery diseaseAnginaCohort StudiesRisk FactorsInternal medicineDiabetes mellitusmedicineSecondary PreventionHumansMyocardial infarctionRisk factorlcsh:ScienceProportional Hazards ModelsMultidisciplinarybusiness.industrylcsh:RHazard ratioMiddle Agedmedicine.diseaseCardiologyRegression Analysislcsh:QFemalebusinessCohort studyResearch ArticleFollow-Up StudiesPLoS ONE
researchProduct

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of li…

2006

Abstract Background The incidence of local reactions to diphtheria-, tetanus and acellular pertussis (DTaP-) vaccines in infants and toddlers increases with each subsequent dose, and entire thigh swellings (ETS) have been reported. Lowering the amount of antigen or of adjuvant may decrease the reactogenicity of DTaP while maintaining a protective immune response. Objectives Following priming with three doses of a DTaP vaccine during infancy, the safety, reactogenicity and immunogenicity of nine different candidate DTaP-vaccines with reduced amounts of antigen and/or adjuvant given as fourth (booster) dose were evaluated. Methods Study participants were healthy infants aged 15–27 months at t…

Malemedicine.medical_specialtymedicine.medical_treatmentDose-Response Relationship ImmunologicImmunization SecondaryBooster doseDiphtheria-Tetanus-acellular Pertussis VaccinesAdjuvants ImmunologicDouble-Blind MethodAntigenInternal medicineHumansMedicineAntigens BacterialReactogenicityGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryTetanusImmunogenicityDiphtheriaPublic Health Environmental and Occupational HealthInfantmedicine.diseaseVaccinationInfectious DiseasesChild PreschoolImmunologyMolecular MedicineFemalebusinessAdjuvantVaccine
researchProduct

Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event.

2017

Background Acute coronary syndrome (ACS) is a major cause of morbidity and mortality. Lifestyle and health behavior changes play an important role in the primary and secondary prevention of ACS recurrence. Changes in unhealthy lifestyles after an acute coronary event have been analyzed by considering separate behaviors individually, even though research on the healthy population has demonstrated that unhealthy behaviors tend to co-occur. Purpose The aim of this study was to identify lifestyle profiles of ACS patients and to explore their pathways of change for one year after their first coronary event by adopting a typological approach. Methods Two hundred and twenty-three patients (84% mal…

Malemedicine.medical_treatmentEmotionsHealth BehaviorSocial Scienceslcsh:MedicineAnxiety030204 cardiovascular system & hematologyHabits0302 clinical medicineMedicine and Health SciencesSmoking HabitsSecondary PreventionPsychologyPublic and Occupational Health030212 general & internal medicinelcsh:ScienceDepression (differential diagnoses)Aged 80 and overSecondary preventionCardiac RehabilitationMultidisciplinaryRehabilitationCoronary eventDepressionSmokingMiddle AgedAcute Coronary Syndrome; Adult; Aged; Aged 80 and over; Cardiac Rehabilitation; Exercise; Female; Humans; Male; Middle Aged; Secondary Prevention; Self Report; Smoking; Health Behavior; Healthy Lifestyle; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)AnxietyFemaleprevention lifestyles acute coronary syndromemedicine.symptomHealth behaviorBehavioral and Social Aspects of HealthResearch ArticleHumanAdultSettore M-PSI/01 - Psicologia Generalemedicine.medical_specialtyAcute coronary syndrome03 medical and health sciencesMental Health and PsychiatryHeart ratemedicineHumansHealthy LifestyleAcute Coronary SyndromeExerciseNutritionAgedBehaviorBiochemistry Genetics and Molecular Biology (all)Mood Disordersbusiness.industrylcsh:RBiology and Life SciencesHealth Risk AnalysisPhysical Activitymedicine.diseaseDietHealth CareAgricultural and Biological Sciences (all)Physical therapylcsh:QSelf ReportbusinessPLoS ONE
researchProduct